✦ LIBER ✦

Application of peripheral blood progenitors to dose-intensive therapy of breast cancer

✍ Scribed by Stephanie F. Williams

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 319 KB
Volume: 26
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf00668357

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Release of peripheral blood progenitor c

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy

✍ Marco Venturini; Lucia Del Mastro; Ornella Garrone; Riccardo Rosso; Giovanni Mel 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Background. High dose chemotherapy with the support of peripheral blood progenitor cells (PBPC) is increasingly used in the treatment of solid tumors. Although the best method of PBPC mobilization is still under investigation, it should be optimized for different tumor types to obtain antitumor effe

A phase II study of intensive-dose epiru

A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer

✍ T. Langenbuch; K. Mross; W. Jonat; D. K. Hossfeld 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 450 KB

Sensitivity of peripheral blood lymphocy

Sensitivity of peripheral blood lymphocytes from breast cancer patients to glucocorticoids

✍ I. A. Ioannesyants; E. B. Polevaya 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 285 KB

Least squares estimation of varying-coef

Least squares estimation of varying-coefficient hazard regression with application to breast cancer dose-intensity data

✍ Guosheng Yin; Hui Li 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 262 KB

Feasibility of dose–intensive continuous

Feasibility of dose–intensive continuous 5–fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancer

✍ Georgiana Ellis; Robert B. Livingston 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

Marker gene transfer into leukapheresis

Marker gene transfer into leukapheresis preparations containing hematopoietic progenitor cells: application in high-dose therapy rescued by reinfusion of peripheral blood hematopoietic progenitors in patients with multiple myeloma

✍ F. Herrmann; M. Kiehntopf; M. A. Brach; D. Carstanjen; C. Schilling 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 748 KB

## Neophosphotransferase MMuL V promoter Retroviral transfer PA-317 Peripheral blood leukapheresis preparations Gene marking of peripheral blood progenitor cells for high dose therapy of multiple myeloma None as of yet 30 One or two per month 2 years (1995)(1996) Abbreviations CDR Complementarity-